LGALS9 and nasopharyngeal carcinoma: In nasopharyngeal carcinoma (NPC), Klibi et al. found that blockade of Galectin-9/Tim-3 interaction could alleviate the Th1-suppressive effect, thus improve antitumoral T-cell responses [26].